跳至主要内容
临床试验/TCTR20180829006
TCTR20180829006进行中(未招募)3 期

Predicting success of nasal high flow therapy in emergency patients with acute hypoxemic respiratory failure by ROX index

Siriraj Research Fund, Faculty of medicine, Siriraj Hospital, Mahidol University0 个研究点目标入组 100 人开始时间: 2018年8月29日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • •respiratory rate more than 24 breaths/min
  • •use of accessory muscle use or abdominal paradox
  • •room air SpO2 equal or less than 90% and need of oxygen supplement via face mask more than 9L/min to maintain SpO2 above 92%

排除标准

  • •cardiac arrest, arrhythmia, ST-elevation myocardial infarction, respiratory arrest, need for immediate intubation, Glasglow Coma Scale (GCS) <12, hemodynamic instability (systolic blood pressure <90 mmHg or mean arterial pressure < 65 mmHg, respiratory acidosis (pH <7.3 and PaCO2 >50 mmHg), suspected hypercapnic respiratory failure (chronic obstructive pulmonary disease, obstructive sleep apnea), RR >35 breaths/min or SpO2 <90% despite oxygen supplement via facemask >9 L/min, pneumothorax and palliative patients

研究者

发起方
Siriraj Research Fund&#44; Faculty of medicine&#44; Siriraj Hospital&#44; Mahidol University

相似试验